Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: Has cancer immunotherapy arrived?
It was Science magazine’s 2013 breakthrough of the year and called a “turning point in cancer.” It even scored its own awareness month that year. Cancer immunotherapy – therapies that harness the power of a patient’s immune system to fight their disease – had officially arrived. Fast-forward three years and now companies are tripping over […]
Right Turn: An art science exhibit on Drs. Till & McCulloch
You would be hard-pressed to find a Canadian stem cell scientist who doesn’t know that Drs. Jim Till and Ernest McCulloch advanced medical research across the globe with their discovery, in 1961, of blood stem cells at Toronto’s Princess Margaret Hospital, today the Princess Margaret Cancer Centre. Recently, a group of artists, doctors, scientists and […]
Right Turn: Canadian procedure stops MS in some patients
In 2002, Jennifer Molson received a stem cell transplant for her aggressive form of multiple sclerosis (MS), diagnosed six years earlier when she was 21. This unique treatment for MS – transplanting blood stem cells from a patient’s own bone marrow to replace the diseased immune system – is now the subject of an article […]
Comments